MFN2 and left ventricular hypertrophy: Hearts deficient in both Mfn1 and Mfn2 had no evidence of cardiomyopathy at 8–10 weeks, with normal left ventricular chamber dimensions and no evidence of left ventricular hypertrophy (normal heart weight/body ratio; Supplementary Figure 1a).